FINWIRES · TerminalLIVE
FINWIRES

Goldman Sachs Adjusts Price Target on Biogen to $250 From $238

By

Biogen (BIIB) has an average rating of overweight and mean price target of $215.86, according to analysts polled by FactSet.

Price: $191.77, Change: $-2.61, Percent Change: -1.34%

What else is happening in Wire?